Month: January 2024

Individual patient response data highlight 91.5% of individuals treated with roflumilast cream had a measurable improvement in Eczema Area and Severity Index (EASI) in just 4 weeks 85% achieved measurable improvement by Week 1 (the earliest timepoint measured) Data presented at the 2024 Winter Clinical Dermatology Conference – HawaiiWESTLAKE VILLAGE, Calif., Jan. 14, 2024 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced new individual patient response data showing the vast majority of individuals (91.5%) treated with investigational roflumilast cream 0.15% had a measurable improvement in Eczema Area and Severity Index (EASI) in 4 weeks. New pooled analyses from two pivotal Phase...

Nørresundby, Denmark, 13 January 2024Announcement no. 03/2024Ordinary board member, Ellen Andersen, who is not appointed for re-election at the forthcoming Annual General Meeting, has informed the company that she wishes to leave the board as of today. Questions and further information: RTX, tel: +45 96 32 23 00AttachmentRTX CA No 03-2024 – 13.01.24 – Ellen Andersen leaves the Board of RTX

HESPERIA, Calif., Jan. 12, 2024 (GLOBE NEWSWIRE) — 5E Advanced Materials, Inc. (Nasdaq: FEAM) (ASX: 5EA) (“5E” or the “Company”), a boron and lithium company with U.S. government Critical Infrastructure designation for its 5E Boron Americas Complex, today announced that its stockholders voted to approve each of the three proposals related to the Company’s out of court restructuring at 5E’s special meeting of stockholders (“Special Meeting”) held earlier today. Susan Brennan, CEO of 5E Advanced Materials, stated, “We are encouraged by the strong support and confidence our shareholders displayed today with the approval of all three proposals. With the recapitalization plan now approved, it gives us ability to further our vision as the newest domestic producer of boric acid and lithium. We would like to thank our shareholders for...

Hole No. Halo-003-23 intersects broad Li-bearing claystone interval with 204 feet (62.2 m) of 994.4 ppm LiFigure 1Map of the POWR Lithium land package showing drill holes and neighboring land positionsFigure 2.Photo of Box #78 of Hole No. Halo-004-23 showing finely laminated claystone which contains in excess of 1,600 ppm lithiumVANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — POWR Lithium Corp. (CSE: POWR) (FRA: 6JX / WKN: A3D6BS) (OTCQB: PWRLF) (“POWR” or the “Company”), a mineral exploration and development company focused on American lithium deposits to support domestic demand, is pleased to provide the complete results from the four-hole, 2,899 feet (883.9-metre) maiden drilling program. The Halo project is located less than 3 kilometres northwest of Tonopah, NV and surrounded by several lithium-exploration...

VANCOUVER, British Columbia, Jan. 12, 2024 (GLOBE NEWSWIRE) — Madison Pacific Properties Inc. (the Company) (TSX: MPC and MPC.C), a Vancouver-based real estate company announces the results of operations for the three months ended November 30, 2023 and declares dividend. The results reported are pursuant to International Financial Reporting Standards (IFRS) for public companies. For the three months ended November 30, 2023, the Company is reporting net loss of $57.8 million (2022: net income of $6.6 million); cash flows generated from operating activities before changes in non-cash operating balances of $1.6 million (2022: cash flow from operating activities before changes in non-cash operating balances of $1.8 million); and loss per share of $0.97 (2022: income per share of $0.11). Included in net loss is a provision of $51.2...

Earnings Release and Conference Call Scheduled for February 21, 2024 Company Also Issues Statement Regarding Customer Communication Celebrating 2023 Achievements and Environmental Impact SAN FRANCISCO, Jan. 12, 2024 (GLOBE NEWSWIRE) — Sunrun (Nasdaq: RUN) today announced that it will issue its fourth quarter and full-year 2023 earnings report after the market closes on Wednesday, February 21, 2024. A conference call has been scheduled to discuss these earnings results at 1:30 p.m. Pacific Time. The conference call can be accessed live via the Sunrun Investor Relations website at https://investors.sunrun.com or over the phone by dialing (877) 407-5989 (toll-free) or (201) 689-8434 (toll). An audio replay will be available following the call on the Sunrun Investor Relations website for approximately one month. A transcript of the...

TORONTO and HOUSTON, Jan. 12, 2024 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTC: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, today announced the appointment of MNP LLP (“MNP” or “Successor Auditor”) as auditor. The board of directors of the Company accepted the resignation of PricewaterhouseCooper LLP (the “Former Auditor”) and appointed MNP as the new auditor until the next annual general meeting of shareholders of the Company. The Company confirms that there have been no reservations or modified opinions in the Former Auditor’s report for the two most recently completed financial years or for any period subsequent to the most recently completed period for which an audit report was issued. The Company’s board of directors and audit committee...

Glen Allen, VA, Jan. 12, 2024 (GLOBE NEWSWIRE) — ENDI Corp. (OTCQB: ENDI) (“ENDI” or the “Company”) today announced its intention to deregister its Class A common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), by filing a Form 15 with the U.S. Securities and Exchange Commission (the “SEC”) on or about January 12, 2024. The filing of the Form 15 will immediately suspend ENDI’s obligation to file current and periodic reports pursuant to the Exchange Act, and effective 90-days thereafter, is expected to terminate the registration of the Company’s Class A common stock under Section 12(g) of the Exchange Act. The Company still intends to file a Form 10-K annual report for its fiscal year ended December 31, 2023 in accordance with SEC requirements. The Company anticipates that as a result of deregistration,...